Harrow, Inc. SEC filings HROW
Harrow, Inc. has 868 filings in SEC EDGAR's recent list, going back to Jul 21, 2006. Its latest annual report, Form 10-K, was filed on Mar 2, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 5, 2026 (material agreement, acquisition or sale of assets, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 25-NSE | Delisting notice | Oct 10, 2025 | — |
| 25-NSE | Delisting notice | Oct 8, 2025 | — |
| NT 10-K | Filing | Mar 17, 2025 | Dec 31, 2024 |
| CERT | Filing | Dec 21, 2022 | — |
| 8-A12B | Filing | Dec 20, 2022 | — |
| 305B2 | Filing | Dec 16, 2022 | — |
| EFFECT | Filing | Jun 6, 2022 | — |
| CORRESP | Letter to the SEC | Jun 1, 2022 | — |
| UPLOAD | Letter from the SEC | Jun 1, 2022 | — |
| EFFECT | Filing | Sep 14, 2021 | — |
| CORRESP | Letter to the SEC | Sep 10, 2021 | — |
| UPLOAD | Letter from the SEC | Sep 10, 2021 | — |
| D | Filing | May 14, 2021 | — |
| CERT | Filing | May 6, 2021 | — |
| 8-A12B | Filing | Apr 20, 2021 | — |
| 305B2 | Filing | Apr 16, 2021 | — |
| SEC STAFF LETTER | Filing | Mar 23, 2021 | — |
| SEC STAFF LETTER | Filing | Feb 23, 2021 | — |
| EFFECT | Filing | Jul 13, 2020 | — |
| CORRESP | Letter to the SEC | Jul 9, 2020 | — |
| UPLOAD | Letter from the SEC | Jul 8, 2020 | — |
| EFFECT | Filing | Jun 16, 2017 | — |
| CORRESP | Letter to the SEC | Jun 14, 2017 | — |
| EFFECT | Filing | Jan 30, 2017 | — |
| CORRESP | Letter to the SEC | Jan 26, 2017 | — |
| UPLOAD | Letter from the SEC | Jan 26, 2017 | — |
| D | Filing | Dec 30, 2016 | — |
| D | Filing | Jan 15, 2015 | — |
| EFFECT | Filing | Sep 29, 2014 | — |
| CORRESP | Letter to the SEC | Sep 26, 2014 | — |
| CORRESP | Letter to the SEC | Sep 19, 2014 | — |
| UPLOAD | Letter from the SEC | Sep 18, 2014 | — |
| CT ORDER | Filing | May 29, 2014 | — |
| CT ORDER | Filing | Feb 14, 2014 | — |
| CT ORDER | Filing | Sep 18, 2013 | — |
| CERTNAS | Auto-generated paper document | Feb 7, 2013 | — |
| EFFECT | Filing | Feb 7, 2013 | — |
| 8-A12B | Registration | Feb 7, 2013 | — |
| D | Filing | May 3, 2012 | — |
| NT 10-K | Form 12b-25 | Mar 31, 2011 | Dec 31, 2010 |
| EFFECT | Filing | May 11, 2009 | — |
| REGDEX | Auto-generated paper document | May 15, 2008 | — |
| 10KSB | Filing | Mar 26, 2008 | Dec 31, 2007 |
| EFFECT | Filing | Feb 8, 2008 | — |
| CORRESP | Letter to the SEC | Feb 7, 2008 | — |
| SB-2/A | Filing | Jan 29, 2008 | — |
| UPLOAD | Letter from the SEC | Jan 28, 2008 | — |
| SB-2/A | Filing | Jan 24, 2008 | — |
| UPLOAD | Letter from the SEC | Jan 23, 2008 | — |
| SB-2/A | Filing | Jan 22, 2008 | — |
| UPLOAD | Letter from the SEC | Jan 4, 2008 | — |
| 8-A12G | Filing | Dec 27, 2007 | — |
| SB-2/A | Filing | Dec 27, 2007 | — |
| UPLOAD | Letter from the SEC | Dec 17, 2007 | — |
| SB-2 | Filing | Dec 7, 2007 | — |
| 10QSB | Filing | Nov 14, 2007 | Sep 30, 2007 |
| REGDEX | Auto-generated paper document | Oct 4, 2007 | — |
| 10QSB | Quarterly report for the period ending 08/07 | Sep 12, 2007 | Aug 31, 2007 |
| 10KSB | 2007 annual year end report | Aug 29, 2007 | May 31, 2007 |
| 10QSB | Quarterly report for the period ending 02/07 | Apr 16, 2007 | Feb 28, 2007 |
| REGDEX | Auto-generated paper document | Feb 27, 2007 | — |
| 10QSB | Quarterly report for the period ending 11/06 | Jan 16, 2007 | Nov 30, 2006 |
| 10QSB | Quarterly report for the period ending 08/06 | Oct 16, 2006 | Aug 31, 2006 |
| EFFECT | Filing | Aug 9, 2006 | — |
| SB-2 | Registration statement | Jul 21, 2006 | — |
Showing 65 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- HROW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Nashville, TN
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1360214
- Former names
- HARROW HEALTH, INC. (until Sep 20, 2023); Imprimis Pharmaceuticals, Inc. (until Dec 17, 2018); TRANSDEL PHARMACEUTICALS INC (until Feb 27, 2012); Bywater Resources, Inc (until Sep 12, 2007)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.